Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
Ironwood Initiates Ph III Study of Linaclotide in IBS-C
Mon, 07/16/18 - 09:06 am
Ironwood Pharmaceuticals
Allergan
linaclotide
Linzess
IBS-C
Ironwood’s preparation for activist-driven R&D split puts 40 staffers out of work
Fierce Pharma
Thu, 07/5/18 - 07:41 pm
Ironwood Pharmaceuticals
R&D
layoffs
Ironwood Pharma’s Sickle Cell Drug Gets Orphan Drug Designation
BioSpace
Sun, 06/10/18 - 07:03 pm
Ironwood Pharmaceuticals
FDA
sickle cell disease
olinciguat
orphan drug
Ironwood pushing through mid-stage trials with nephropathy drug
BioPharma Dive
Tue, 12/5/17 - 09:35 am
Ironwood Pharmaceuticals
clinical trials
diabetic nephropathy
IW-1973
Allergan: Is Linzess 'Restasis 2.0'?
NY Shock Exchange
Mon, 10/23/17 - 09:42 am
Allergan
Restasis
patents
Linzess
Ironwood Pharmaceuticals
Teva Pharmaceutical
IBS-C
Ironwood zeroes in on primary care doctors with new gout combo med Duzallo
Fierce Pharma
Wed, 08/23/17 - 11:15 am
Ironwood Pharmaceuticals
gout
Duzallo
primary care
AstraZeneca hands off Zurampic marketing rights to Ironwood for $100 million
BioPharma Dive
Wed, 04/27/16 - 02:11 pm
AstraZeneca
Zurampic
Ironwood Pharmaceuticals
gout
Ironwood exec's brainstorm gives Allergan a marketing edge with Linzess
Fierce Pharma Marketing
Thu, 04/7/16 - 09:44 pm
Ironwood Pharmaceuticals
Allergan
Linzess
Is This Ironwood Pharmaceuticals' Biggest Threat?
Motley Fool
Mon, 03/21/16 - 09:11 am
Ironwood Pharmaceuticals
Linzess
plecanatide
Synergy Pharmaceuticals
Ironwood marks rare milestone: 1 million patients have taken Linzess
Bizjournals.com
Thu, 02/18/16 - 05:53 pm
Ironwood Pharmaceuticals
Linzess
IBS-C
3 Biotech Stocks That Are Getting a Heckuva Lot Riskier
Motley Fool
Mon, 08/17/15 - 07:58 am
Ironwood Pharmaceuticals
Aegerion
MannKind
Companies Betting on the Next 10 Blockbuster Drugs
24/7WallStreet
Wed, 04/23/14 - 11:57 am
Juxtapid
Otezla
Aegerion
Celgene
GW Pharma
Sativex
Intercept Pharma
OCA
Ironwood Pharmaceuticals
Linzess
Lpath
iSONEP
MannKind
Afrezza
Xtandi
H.P. Acthar Gel
Questcor Pharmaceuticals
eteplirsen
Sarepta Therapeutics
Why Ironwood Pharmaceuticals (IRWD) is Poised to Beat Earnings Estimates (Again)
Yahoo/Zacks.com
Wed, 04/23/14 - 09:18 am
earnings
Ironwood Pharmaceuticals
Previous Data Signals Positive Phase IIb Results Likely To Come For Synergy Pharmaceuticals
Seeking Alpha
Fri, 02/21/14 - 11:19 am
Synergy Pharmaceuticals
IBS-C
Ironwood Pharmaceuticals
Linzess
Sucampo
plecanatide
Narrower-than-Expected Loss at Ironwood, Shares Up
Yahoo/Zacks.com
Wed, 01/22/14 - 05:19 pm
earnings
Ironwood Pharmaceuticals
5 Pharmas Spending the Most on Advertising to Physicians in Print Media
Motley Fool
Thu, 09/5/13 - 06:50 pm
JNJ
Forest Labs
Pfizer
Novartis
Ironwood Pharmaceuticals
Ironwood Pharma 2Q loss widens, revenue slides
Yahoo/AP
Tue, 07/23/13 - 11:56 am
earnings
Ironwood Pharmaceuticals
Ironwood commences first phase of anxiety drug trial in US
Pharmaceutical Business Review
Wed, 12/26/12 - 12:05 pm
Ironwood Pharmaceuticals
anxiety
IW-2143
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Sat, 12/15/12 - 01:28 pm
Xtandi
Medivation
prostate cancer
Stribild
Gilead Sciences
HIV
Belviq
Arena Pharmaceuticals
obesity
weight loss
Qsymia
Vivus
Kyprolis
ONYX Pharmaceuticals
Multiple Myeloma
Omontys
Affymax
anemia
Linzess
irritable bowel syndrome
Ironwood Pharmaceuticals
Bosulif
chronic myeloid leukemia
Pfizer
Amyvid
Alzheimer's disease
Eli Lilly
Eylea
macular degeneration
Regeneron
Ironwood long-term outlook positive, says Ladenburg
Yahoo/Fly on the Wall
Tue, 10/23/12 - 04:29 pm
Ironwood Pharmaceuticals
linaclotide
AstraZeneca
China
Pages
« first
‹ previous
1
2
3
next ›
last »